Stock market news
Severstal will reduce capex by half
Severstal plans to cut its capital investments by about half of last year's peak in 2027. Company's preliminary investment program for next year could be around ₽85 billion, and the issue will be unde…
Genetico has launched Onconetix Maxi
Genetico has introduced a new product for tumor research, Onconetix Maxi. This is an onco-genetic study based on next-generation sequencing (NGS), which allows for a detailed and informative examinati…
Fesco has launched a container train service
Fesco has launched a railway service, FESCO Caravan Shuttle, for the delivery of containerized cargo from Chinese cities to Kazakhstan and Uzbekistan via the Dostyk and Altynkol land border crossings.…
X5 intends to buy the alcohol distributor Region 50
X5 is in talks to buy the alcohol company Region 50, Kommersant's sources said. According to one of them, X5 intends to merge this business with its Okolo chain of stores, which is developing through …
MGKL shareholders did not approve dividends for the year
MGCL shareholders voted against paying dividends for 2025 in the amount of ₽0.28 per ordinary share.
MGL's revenue in January-June increased by 2.6 times
MGC's revenue In the 6 months of 2026 amounted to ₽26.4 billion, an increase of 2.6 times compared to the previous year. Number of retail customers increased by 28% to 132.7 thousand. Share of goods s…
Shareholders of Komi Power Supply Company approved dividends
Shareholders of Komi Energy Sales Company approved dividends for the 2025 year in the amount of ₽0.098842929270126 per ordinary and preferred share. The last day to purchase shares for receiving divid…
Shareholders of Rosneft-Smolensknefteprodukt approved dividends
Shareholders of Rosneft-Smolensknefteproduct approved dividends for the 2025 year in the amount of ₽478.76 per preferred share. The last day to purchase shares for receiving dividends is July 9, 2026.…
Kamaz shareholders approved a three-year additional issue
Kamaz shareholders approved an additional issue by closed subscription in favor of Rosimushchestvo and FSUE NAMI. It is planned to place 234,487,564 shares, which is 24.9% of the increased authorized …
MMCB invests in gene therapy for neuromuscular diseases
MMCB investing ₽15 million in Orfagenex, a biotechnology startup developing gene therapies for the treatment of rare (orphan) neuromuscular diseases, including spinal muscular atrophy (SMA). So far, ₽…
- BlackTerminal.com 2016 - 2026.